Skbloom

https://www.dovepress.com/a-review-of-randomized-controlled-trials-of-hereditary-angioedema-long-peer-reviewed-fulltext-article-JAA

Long term prophylaxis for HAE with C1 inhibitor | JAA

Mar 9, 2023 ... C1-INH replacement therapy is a first-line intervention for on-demand (acute) treatment of HAE attacks, short-term prophylaxis before high-risk procedures, and ...

PubMed Central (PMC)

https://pmc.ncbi.nlm.nih.gov/articles/PMC2621399/

Treatment of hereditary angioedema with plasma-derived C1 inhibitor

Serologic testing for hepatitis C began in 1993, and has since advanced to include screening for other viruses. ... Replacement therapy in hereditary angioedema: ...

https://www.nejm.org/doi/full/10.1056/NEJMoa1613627

Prevention of Hereditary Angioedema Attacks with a Subcutaneous ...

Mar 23, 2017 ... C1 inhibitor replacement for prophylaxis is currently approved only as intravenous therapy. Its use was first described in two case reports in ...

PubMed Central (PMC)

https://pmc.ncbi.nlm.nih.gov/articles/PMC9510393/

Treatment of hereditary angioedema—single or multiple pathways to ...

Current options for the treatment and prevention of HAE attacks include treating all affected pathways via direct C1-INH replacement therapy.

PubMed

https://pubmed.ncbi.nlm.nih.gov/11718165/

C1 esterase inhibitor: new preparation. A major advance in ...

C1 esterase inhibitor is now licensed in France as replacement therapy for patients with hereditary angioneurotic oedema due to a quantitative or qualitative ...

Annals of Allergy, Asthma & Immunology

https://www.annallergy.org/article/S1081-1206(20)30333-1/fulltext

Long-term safety and efficacy of subcutaneous C1-inhibitor in older ...

May 19, 2020 ... ∙ Kashkin, J. Update on the use of C1-esterase inhibitor replacement therapy in the acute and prophylactic treatment of hereditary angioedema.

https://link.springer.com/article/10.1007/s40629-018-0088-5

Guideline: Hereditary angioedema due to C1 inhibitor deficiency ...

Jan 17, 2019 ... Treatment of laryngeal edema in the setting of HAE-C1-INH depends on how advanced laryngeal edema is. In the case of life-threatening ...

https://discovery.ucl.ac.uk/id/eprint/10089106/

Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement ...

Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks ... Advanced Search · Contact Us · UCL ...

https://aacijournal.biomedcentral.com/articles/10.1186/1710-1492-6-18

Pediatric hereditary angioedema due to C1-inhibitor deficiency ...

Jul 28, 2010 ... ... C1-INH replacement therapy. Current guidelines favour ... advanced maternal age, AFP abnormality, ultrasound findings suggestive of ...

https://www.sciencedirect.com/science/article/pii/S2213219818300333

Health-Related Quality of Life with Subcutaneous C1-Inhibitor for ...

... C1-Inhibitor Replacement Therapy). Ninety patients with C1-INH-HAE were ... advance in HAE management, improving anxiety and enabling patients with C1 ...

Recommendation

Recommendation